Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001655016-26-000002

Director acquired 339 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fox Jonathan C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-01 Grant or award : show line 1 in the form +339 24,514 D
Loading xslF345X06/primarydocument.xml…